Today's (13.04.2026) Total Trades: 222,205; Volume: 279,933,066 and Turnover: Tk. 7,934.264 million.

Today's (13.04.2026) Total Trades: 222,205; Volume: 279,933,066 and Turnover: Tk. 7,934.264 million.

(Cont. news of PHARMAID): 1. Mrs. Shahinoor Baby, Wife, Sponsor Director and Chairman of the Company, will receive 18,688 shares; 2. Mr. Md. Nurul Mahbub, Son, will receive 52,325 shares; 3. Mrs. Farzina Binty Masud, Daughter, will receive 26,162 shares; and 4. Mr. Mahir Musleh, Son, will receive 52,325 shares. (end)

(Cont. news of PHARMAID): 1. Mrs. Shahinoor Baby, Wife, Sponsor Director and Chairman of the Company, will receive 18,688 shares; 2. Mr. Md. Nurul Mahbub, Son, will receive 52,325 shares; 3. Mrs. Farzina Binty Masud, Daughter, will receive 26,162 shares; and 4. Mr. Mahir Musleh, Son, will receive 52,325 shares. (end)

The Company has informed that 149,500 shares held by Late M. A. Masud, a Sponsor Director and former Chairman of the Company, who passed away on 11.11.2025, will be transmitted among his successors in accordance with the Succession Certificate issued by the Honorable Court. The names of the successors, their relationships with the deceased shareholder, and the number of shares to be received by each successor are as follows: (cont.)

The Company has informed that 149,500 shares held by Late M. A. Masud, a Sponsor Director and former Chairman of the Company, who passed away on 11.11.2025, will be transmitted among his successors in accordance with the Succession Certificate issued by the Honorable Court. The names of the successors, their relationships with the deceased shareholder, and the number of shares to be received by each successor are as follows: (cont.)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 23, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 23, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026.